Prevalence of Ever-Diagnosed ASD 2.79 Percent in U.S. Children

The prevalence of ever-diagnosed autism spectrum disorder (ASD) is 2.79 percent in the United States, with state-level variations in prevalence, according to a study published online Dec. 3 in JAMA Pediatrics.
Guifeng Xu, M.D., from the University of Iowa in Iowa City, and colleagues used cross-sectional data from the 2016 National Survey of Children's Health to estimate the prevalence and treatment patterns of ASD among young children. Data were included for 43,032 children aged 3 to 17 years and were obtained from questionnaires completed by a parent or guardian.
The researchers found the weighted prevalence of ever-diagnosed and current ASD was 2.79 and 2.50 percent, respectively. There was variation in the state-level prevalence of ever-diagnosed ASD from 1.54 percent in Texas to 4.88 percent in Florida. About 70 percent of children with current ASD were treated nationally: 43.3, 6.9, and 20.3 percent received behavioral treatment only, medication only, and both behavioral and medication treatments, respectively; 29.5 percent did not receive behavioral or medication treatment.
"Continued monitoring of the prevalence and treatment of ASD is warranted," the authors write. "Future research and policy efforts are critically needed to understand and address the barriers for children with ASD to receive appropriate treatments."
2026-10-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Is India’s “Luck” Finally Here? HPCL’s 10-Year LNG Deal Is a High-Stakes Bet on National Destiny
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
After 20 Years of Negotiations, 90% of Tariffs to Be Cut! EU and Mercosur Sign Free Trade Agreement: Trade Barriers Ease, Transatlantic Cooperation Warms Up?
-
MDI Price Surge Hits EMEAI: Is This a Market Correction or the Beginning of a Supply Crisis?
-
“Deregulation” or “Concession”? The Hidden Crisis Behind India’s Repeal of QCOs on Seven Key Petrochemicals
-
“Soaring Sulfuric Acid, Tightening Ore Supplies”: The High-Stakes Battle Behind the Titanium Dioxide Price Surge
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
Australia Approves Lab-Grown “Milk Sugar” for Babies—A Breakthrough in Infant Nutrition
-
From Coffee Waste to Superfood Additive: EU Declares Pectin-Rich Arabica Extract Safe for Food Use
-
Sekisui Specialty Chemicals Has Announced a Global Price Increase
Recommend Reading
-
Profits Are Rising, but So Are the Risks—China’s Coatings Industry Is Living Through Its Most Awkward Year
-
Oil-Coal Price Gap Widens! Coal Chemical Enterprises See Significant Profit Surge in H1 2026
-
DIC Raises Epoxy Resin and Curing Agent Prices by Up to 280 Yen/kg
-
Lubei Chemical Expects First-Quarter Net Profit to Rise 57.29% as Cost Control Delivers Clear Results
-
Ten Ministries Jointly Issue Notice as Five Chemicals Are Officially Added to the Hazardous Chemicals Catalogue
-
May Shandong Asphalt Market Ranges Within a Narrow Trading Band
-
Dichloromethane Stabilizes First, Then Collapses
-
Caustic Soda Prices Overall Decline in May
-
May MIBK Market Weakens and Moves Narrowly Lower; Downward Momentum Slows at Month’s End
-
Cost-Driven Stronger Rise in Phosphate Market in May